scholarly article | Q13442814 |
P356 | DOI | 10.1038/CLPT.1989.176 |
P698 | PubMed publication ID | 2582706 |
P2093 | author name string | S Broder | |
R Yarchoan | |||
S S Good | |||
M R Blum | |||
C E Myers | |||
P de Miranda | |||
R V Thomas | |||
P433 | issue | 5 | |
P921 | main subject | AIDS-related complex | Q4651855 |
zidovudine | Q198504 | ||
pharmacokinetics | Q323936 | ||
P304 | page(s) | 494-500 | |
P577 | publication date | 1989-11-01 | |
P1433 | published in | Clinical Pharmacology & Therapeutics | Q1101529 |
P1476 | title | Alteration of zidovudine pharmacokinetics by probenecid in patients with AIDS or AIDS-related complex | |
P478 | volume | 46 |
Q46577857 | A simplified analysis of [18F]3'-deoxy-3'-fluorothymidine metabolism and retention |
Q37302739 | Association Between the Occurrence of Adverse Drug Events and Modification of First-Line Highly Active Antiretroviral Therapy in Ghanaian HIV Patients |
Q46691027 | Atovaquone inhibits the glucuronidation and increases the plasma concentrations of zidovudine |
Q41292984 | Clinical pharmacokinetics of zidovudine. An update |
Q44129880 | Clinical pharmacokinetics of zidovudine: inter and intraindividual variability and relationship to long term efficacy and toxicity. |
Q40487397 | Clinical pharmacology of zidovudine and other 2?,3?-dideoxynucleoside analogues |
Q40886850 | Comparative pharmacokinetics of antiviral nucleoside analogues |
Q44477319 | Competitive inhibition of zidovudine clearance by probenecid during continuous coadministration |
Q68207621 | Direct measurement of probenecid and its glucuronide conjugate by means of high pressure liquid chromatography in plasma and urine of humans |
Q35072074 | Drug interactions between antiretroviral drugs and comedicated agents |
Q36558235 | Effect of maraviroc on the pharmacokinetics of midazolam, lamivudine/zidovudine, and ethinyloestradiol/levonorgestrel in healthy volunteers |
Q44663198 | Effect of probenecid and quinidine on the transport of alovudine (3'-fluorothymidine) to the rat brain studied by microdialysis |
Q72281592 | Effect of probenecid on the formation and elimination kinetics of the sulphate and glucuronide conjugates of diflunisal |
Q35372195 | Glucuronidation of drugs. A re-evaluation of the pharmacological significance of the conjugates and modulating factors |
Q36646145 | Hematologic Effects of AIDS Therapies |
Q41537511 | Inhibitory Interaction Potential of 22 Antituberculosis Drugs on Organic Anion and Cation Transporters of the SLC22A Family |
Q36757870 | Intravenous and oral zidovudine pharmacokinetics and coagulation effects in asymptomatic human immunodeficiency virus-infected hemophilia patients |
Q73850558 | Investigation of distribution, transport and uptake of anti-HIV drugs to the central nervous system |
Q35124869 | Lack of effect of concomitant zidovudine on rifabutin kinetics in patients with AIDS-related complex |
Q41619438 | Liver slices as a model in drug metabolism. |
Q43738146 | Pharmacokinetic Evaluation of Drug Interactions with Zidovudine. I: Probenecid and Zidovudine in Monkeys |
Q40720380 | Pharmacokinetic drug interactions with antimicrobial agents |
Q45880071 | Pharmacokinetic evaluation of drug interactions with anti-human immunotrophic virus (HIV) Drugs. III. 2',3'-Dideoxycytidine (ddC) and zidovudine in monkeys |
Q35138941 | Pharmacokinetic interaction of megestrol acetate with zidovudine in human immunodeficiency virus-infected patients |
Q35120894 | Pharmacokinetics and bioavailability of zidovudine and its glucuronidated metabolite in patients with human immunodeficiency virus infection and hepatic disease (AIDS Clinical Trials Group protocol 062). |
Q71117298 | Pharmacokinetics of lamivudine administered alone and with trimethoprim-sulfamethoxazole |
Q38511971 | Pharmacokinetics, oral bioavailability, and metabolic disposition in rats of (-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl] cytosine, a nucleoside analog active against human immunodeficiency virus and hepatitis B virus |
Q39545308 | Probenecid interferes with renal oxidative metabolism: a potential pitfall in its use as an inhibitor of drug transport |
Q44383564 | Probenecid-induced changes in the clearance of pranoprofen enantiomers |
Q39140289 | Renal Drug Transporters and Drug Interactions |
Q71485760 | Renal disposition and drug interaction screening of (-)-2'-deoxy-3'-thiacytidine (3TC) in the isolated perfused rat kidney |
Q43224428 | Sodium valproate acutely inhibits lamotrigine metabolism |
Q72361391 | The effect of probenecid on paracetamol metabolism and pharmacokinetics |
Q53991051 | The effect of probenecid on the pharmacokinetics of zalcitabine in HIV-positive patients. |
Q34358547 | The effect of various drugs on the glucuronidation of zidovudine (azidothymidine; AZT) by human liver microsomes |
Q34345495 | The effects of indomethacin and naproxen on zidovudine pharmacokinetics |
Q33933489 | Transport, metabolism and elimination mechanisms of anti-HIV agents |
Q34403379 | Trimethoprim, alone or in combination with sulphamethoxazole, decreases the renal excretion of zidovudine and its glucuronide |
Q39782074 | Zidovudine, trimethoprim, and dapsone pharmacokinetic interactions in patients with human immunodeficiency virus infection |
Q40491653 | Zidovudine. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy |